Page last updated: 2024-08-26

dehydroabietic acid and fluorouracil

dehydroabietic acid has been researched along with fluorouracil in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, XC; Pan, YM; Tian, XY; Wang, HS; Wang, M; Zhang, Y1
Huang, XC; Pan, YM; Qin, JK; Tian, XY; Wang, HS; Wang, M; Yao, GY; Zhang, Y1
Chen, ZF; Huang, XC; Pan, YM; Wang, HS; Wang, M; Zhang, Y1
Chen, ZF; Huang, XC; Jin, L; Liang, D; Pan, YM; Wang, HS; Wang, M; Zhang, Y1
Gou, S; Huang, R; Huang, X; Liao, Z; Pan, Y; Wang, H1
Fan, X; Jiang, B; Li, Y; Liu, L; Xu, H; Zhang, G1
Huang, RZ; Huang, XC; Liang, GB; Liao, ZX; Wang, HS; Zhang, B; Zhou, MM1

Other Studies

7 other study(ies) available for dehydroabietic acid and fluorouracil

ArticleYear
Synthesis and antitumor activities of novel α-aminophosphonates dehydroabietic acid derivatives.
    Bioorganic & medicinal chemistry letters, 2013, Oct-01, Volume: 23, Issue:19

    Topics: Abietanes; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Drug Evaluation, Preclinical; Flow Cytometry; Humans; Inhibitory Concentration 50; Molecular Structure; Organophosphonates

2013
Synthesis and antitumor activities of novel thiourea α-aminophosphonates from dehydroabietic acid.
    European journal of medicinal chemistry, 2013, Volume: 69

    Topics: Abietanes; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Molecular Structure; Organophosphonates; Structure-Activity Relationship; Thiourea

2013
Synthesis and antitumor activities of novel dipeptide derivatives derived from dehydroabietic acid.
    Bioorganic & medicinal chemistry letters, 2014, Mar-15, Volume: 24, Issue:6

    Topics: Abietanes; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Dipeptides; DNA Fragmentation; Drug Screening Assays, Antitumor; HCT116 Cells; HeLa Cells; Humans; Phenanthrenes; Phenylalanine; Reactive Oxygen Species

2014
Design, synthesis and in vitro evaluation of novel dehydroabietic acid derivatives containing a dipeptide moiety as potential anticancer agents.
    European journal of medicinal chemistry, 2015, Jan-07, Volume: 89

    Topics: Abietanes; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; Cytochromes c; Dipeptides; Drug Design; Flow Cytometry; Humans; In Situ Nick-End Labeling; Membrane Potential, Mitochondrial; Microscopy, Fluorescence; Molecular Structure; Reactive Oxygen Species

2015
Synthesis and pharmacological evaluation of dehydroabietic acid thiourea derivatives containing bisphosphonate moiety as an inducer of apoptosis.
    European journal of medicinal chemistry, 2016, Jan-27, Volume: 108

    Topics: Abietanes; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Cell Survival; Diphosphonates; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Structure-Activity Relationship; Thiourea; Tumor Cells, Cultured

2016
Identification of a diverse synthetic abietane diterpenoid library for anticancer activity.
    Bioorganic & medicinal chemistry letters, 2017, 02-01, Volume: 27, Issue:3

    Topics: Abietanes; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Membrane Potential, Mitochondrial; Molecular Structure; Structure-Activity Relationship

2017
Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
    European journal of medicinal chemistry, 2017, Sep-29, Volume: 138

    Topics: Abietanes; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Sulfonamides

2017